| |
| |
|
| Insider
Information: |
Hochman David P |
| Relationship: |
See Remarks, Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
4,762,388 |
|
|
Indirect Shares
|
5,399,282 |
|
|
| Direct
Value |
$23,725,605 |
|
|
|
Indirect Value
|
$13,278,318 |
|
|
| Total
Shares |
10,161,670 |
|
|
| Total
Value |
$37,003,923 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orchestra Therapeutics |
OCHTQ |
Director |
2006-08-21 |
3,375,000 |
2006-08-21 |
2,600,000 |
Premium* |
|
|
Corbus Pharmaceuticals Holdings,... |
CRBP |
Director |
2019-03-15 |
459,500 |
2019-03-15 |
244,900 |
Premium* |
|
|
Naked Brand Group Inc |
NAKD |
Director, 10% Owner |
2017-01-12 |
70,721 |
2017-01-12 |
43,810 |
Premium* |
|
|
Motus Gi Holdings Inc |
MOTS |
Chairman of the Board,... |
2022-01-05 |
291,669 |
2022-01-05 |
2,178,070 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
See Remarks, Director |
2024-05-17 |
565,498 |
2024-05-17 |
332,502 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NAKD |
Naked Brand Group Inc |
Director |
– • – |
2014-12-10 |
4 |
A |
$0.08 |
$4,074 |
D/D |
54,320 |
54,320 |
0 |
- |
|
| NAKD |
Naked Brand Group Inc |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.08 |
$4,074 |
D/D |
54,320 |
108,640 |
0 |
- |
|
| NAKD |
Naked Brand Group Inc |
Director |
– • • |
2017-01-12 |
4 |
A |
$1.04 |
$12,210 |
D/D |
11,740 |
70,721 |
0 |
- |
|
| CRBP |
Corbus Pharmaceuticals Ho... |
Director |
– • – |
2017-11-13 |
4 |
A |
$6.90 |
$34,500 |
I/I |
5,000 |
215,000 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
I/I |
164,786 |
1,159,968 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • • |
2018-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
78,000 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2018-05-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,000,000 |
2,000,000 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
38,307 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2020-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
18,466 |
71,373 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2021-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,741 |
92,114 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
72,472 |
164,586 |
0 |
- |
|
| MOTS |
Motus Gi Holdings Inc |
Chairman of the Board |
– • – |
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
127,083 |
291,669 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
I/I |
54,482 |
3,140 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2023-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
135,947 |
135,947 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2023-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
465,498 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2023-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
165,000 |
227,502 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
565,498 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
I/I |
100,000 |
327,502 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2024-05-16 |
4 |
A |
$4.75 |
$9,500 |
I/I |
2,000 |
329,502 |
0 |
- |
|
| OBIO |
Orchestra BioMed Holdings... |
See Remarks |
• • – |
2024-05-17 |
4 |
A |
$5.15 |
$15,450 |
I/I |
3,000 |
332,502 |
0 |
- |
|
| OCHTQ |
Orchestra Therapeutics |
Director |
– • – |
2006-06-14 |
4 |
B |
$0.02 |
$10,000 |
D/D |
500,000 |
2,375,000 |
2.39 |
- |
|
| OCHTQ |
Orchestra Therapeutics |
Director |
– • – |
2006-06-19 |
4 |
B |
$0.02 |
$4,000 |
D/D |
200,000 |
2,575,000 |
2.31 |
- |
|
| OCHTQ |
Orchestra Therapeutics |
Director |
– • – |
2006-07-27 |
4 |
B |
$0.02 |
$6,600 |
D/D |
300,000 |
2,875,000 |
2.39 |
- |
|
| OCHTQ |
Orchestra Therapeutics |
Director |
– • – |
2006-07-28 |
4 |
B |
$0.02 |
$59,800 |
I/I |
2,600,000 |
2,600,000 |
2.1 |
- |
|
| OCHTQ |
Orchestra Therapeutics |
Director |
– • – |
2006-08-21 |
4 |
B |
$0.02 |
$9,000 |
D/D |
500,000 |
3,375,000 |
2.39 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
